CBR1 Antikörper
-
- Target Alle CBR1 Antikörper anzeigen
- CBR1 (Carbonyl Reductase 1 (CBR1))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CBR1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant protein of human CBR1
- Isotyp
- IgG
- Top Product
- Discover our top product CBR1 Primärantikörper
-
-
- Applikationshinweise
- WB 1:1000-1:5000, IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CBR1 (Carbonyl Reductase 1 (CBR1))
- Andere Bezeichnung
- CBR1 (CBR1 Produkte)
- Synonyme
- LOC100222525 antikoerper, MGC131152 antikoerper, CBR antikoerper, SDR21C1 antikoerper, hCBR1 antikoerper, 9-KPR antikoerper, AW261796 antikoerper, CR antikoerper, Cbr antikoerper, carbonyl reductase 1 antikoerper, carbonyl reductase [NADPH] 1 antikoerper, carbonyl reductase 1 S homeolog antikoerper, carbonyl reductase antikoerper, cbr1 antikoerper, CBR1 antikoerper, LOC100222525 antikoerper, cbr1.S antikoerper, Smp_033530.3 antikoerper, LOC610164 antikoerper, Cbr1 antikoerper
- Hintergrund
- Carbonyl reductase is one of several monomeric, NADPH-dependent oxidoreductases having wide specificity for carbonyl compounds. This enzyme is widely distributed in human tissues. Another carbonyl reductase gene, CRB3, lies close to this gene on chromosome 21q. NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol.
- Molekulargewicht
- 30 kDa
- UniProt
- P16152
-